Latest Schedule 13D activist filings

Pershing Square Capital Management and William A. Ackman have reduced their beneficial ownership in Restaurant Brands International Inc. following a series of share sales.

Star Equity Fund, a 5.4% shareholder in GEE Group, is demanding the removal of excessive change-in-control severance provisions for top executives to facilitate a potential company sale.

RA Capital Management disclosed a significant investment in Climb Bio, Inc. through a private placement of common stock and pre-funded warrants.

XOMA Royalty Corp. announces a merger agreement with Ligand Pharmaceuticals Inc., with key shareholders entering a support agreement to vote in favor of the transaction.

RTW Investments, LP and affiliated funds have increased their beneficial ownership in Orchestra Biomed Holdings, Inc. to 19.2% following the cashless exercise of pre-funded warrants.

Wells Fargo entities report no longer holding preferred shares in Nuveen New Jersey Quality Municipal Income Fund following a reorganization into NMZ.

Wells Fargo entities report no longer holding preferred shares in Nuveen New Jersey Quality Municipal Income Fund following a reorganization into NMZ.

Wells Fargo & Company and its affiliate report a significant stake in Nuveen Municipal High Income Opportunity Fund following a corporate reorganization.

Wells Fargo & Company and its affiliate report a significant stake in Nuveen Municipal High Income Opportunity Fund following a corporate reorganization.

Wells Fargo & Company and its affiliate report no longer owning VRDP Shares of Nuveen Pennsylvania Quality Municipal Income Fund following a reorganization.

Wells Fargo & Company and its affiliate report no longer owning VRDP Shares of Nuveen Pennsylvania Quality Municipal Income Fund following a reorganization.

Several significant shareholders in Indaptus Therapeutics have formally disbanded their reporting group, with one shareholder falling below the 5% ownership threshold.

Smart Share Global Limited announced the effectiveness of its merger, leading to its delisting from the Nasdaq Capital Market and the termination of its ADS program.

Bank of America Corporation and its subsidiary have filed an amendment to their Schedule 13D, reporting a change in their ownership percentage of Nuveen Municipal High Income Opportunity Fund's preferred shares following a corporate reorganization.

Bank of America Corporation and its subsidiary have filed an amendment to their Schedule 13D, reporting a change in their ownership percentage of Nuveen Municipal High Income Opportunity Fund's preferred shares following a corporate reorganization.

LakeShore Biopharma Co., Ltd. announces an amendment to its merger agreement, reducing the per-share consideration and adjusting termination fees.

DoubleU Games Co., Ltd. has issued a non-binding proposal to acquire all remaining shares of DoubleDown Interactive for $11.25 per ADS in a deal valued at approximately $184 million.

Lynrock Lake LP has filed an amendment to its Schedule 13D, disclosing a series of open-market sales of RADCOM Ltd ordinary shares.

Whitefort Capital Master Fund has adjusted its position in Arbutus Biopharma, reaching an 8.0% beneficial ownership stake and 9.8% total economic exposure.

Investor David E. Lazar has acquired a 97.4% stake in Mainz Biomed N.V. and has been appointed as the new Chief Executive Officer.

Bloom Retirement Holdings Inc. and Reza Jahangiri report a 9.49% stake in Finance of America Companies Inc. Class A Common Stock following a forfeiture of units.

Hong Zhifang and RongStar Holdings Ltd report beneficial ownership of 20.69% of DarkIris Inc. Class A Ordinary Shares, detailing recent share purchases and their control over voting rights.

Arcellx, Inc. has been acquired by Gilead Sciences, Inc. through a tender offer and subsequent merger, with shareholders receiving $115 per share plus a contingent value right.

Horizon Kinetics Asset Management LLC has increased its beneficial ownership in Miami International Holdings, Inc. to 12.2%, coinciding with the election of a Horizon Kinetics representative to the company's Board of Directors.

Cheddi Rai has filed a Schedule 13D, revealing beneficial ownership of approximately 12.1% of Visium Technologies' common stock, primarily in connection with a proposed acquisition and future executive roles.

Gran Fondo Capital B.V. and Rorema Beheer B.V. have filed an amendment to their Schedule 13D, reporting a combined beneficial ownership of 632,451 shares, representing 4.2% of TruBridge, Inc.'s common stock.

Veradace Capital Management and its affiliates have nominated Alexander Vezendan and William Jacobs for election to the Repay Holdings Corp. board, citing material changes in the company's circumstances.

Bioceres Crop Solutions Corp. reports a decrease in beneficial ownership by Agriculture Investment Group Corp. and Granosur Holding Limited, with over 700,000 shares sold in recent transactions.

Gilead Sciences has finalized its acquisition of Arcellx, Inc. following a successful tender offer and subsequent merger, making Arcellx a wholly owned subsidiary.

Gilead Sciences has finalized its acquisition of Arcellx, Inc. following a successful tender offer and subsequent merger, making Arcellx a wholly owned subsidiary.